Serum uric acid in hypertensive patients

Area of Science:

• Nephrology
• Cardiovascular Medicine
• Clinical Chemistry

Background:

• Elevated serum uric acid (hyperuricemia) is a common finding in patients with hypertension.
• Understanding factors influencing uric acid levels is crucial for managing hypertensive patients.

Purpose of the Study:

• To determine average serum uric acid levels and annual increments in treated hypertensive patients.
• To identify factors associated with elevated uric acid and its changes over time.

Main Methods:

• Serum uric acid levels and annual increments were analyzed in 250 hypertensive patients.
• Data collected included patient demographics, medication use (thiazide diuretics, methyldopa), plasma urea, and blood pressure control.

Main Results:

• Average serum uric acid was higher in men, patients on thiazide diuretics, and those with high plasma urea.
• The mean annual increment in uric acid was negligible (0.0017 mmol/litre per year) and not significantly associated with sex, age, blood pressure control, or plasma urea.
• An unexplained positive association was observed between annual increment and methyldopa therapy.

Conclusions:

• Thiazide diuretics and high plasma urea are associated with higher average serum uric acid in hypertensive patients.
• Annual changes in serum uric acid are minimal in treated hypertensive patients.
• A reference table for theoretical upper limits of serum uric acid is provided to aid clinical assessment.